Review



fitc ly6c  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Miltenyi Biotec fitc ly6c
    Fitc Ly6c, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 71 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/Ly-6C+Antibody%2C+anti-mouse%2C+FITC/pmc11730596__41467_2024_55272_MOESM10_ESM-41-134-136
    Average 94 stars, based on 71 article reviews
    fitc ly6c - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Staining:

    Article Title: Altered X-chromosome inactivation predisposes to autoimmunity
    Article Snippet: Levels of inflammatory cytokines in sera were measured using a cytometric bead array mouse inflammation kit (552364, BD Biosciences) according to the manufacturer’s instructions. .. BM, spleen, blood, and peritoneal cavity cells were stained using the following antibodies: CD3 PerCP-Vio770 (130-119-656, Miltenyi Biotec), CD4-allophycocyanin (APC) (130-123-207, Miltenyi Biotec), CD5-APC-Vio770 (130-120-165, Miltenyi Biotec), CD8-fluorescein isothiocyanate (FITC) (130-118-468, Miltenyi Biotec), CD11b APC (553312, BD Pharmingen), CD11c phycoerythrin (PE)–Vio770 (130-110-840, Miltenyi Biotec), CD19-FITC (557398, BD Pharmingen), CD21-APC-Vio770 (130-111-733, Miltenyi Biotec), CD23-PE-Vio770 (130-118-764, Miltenyi Biotec), CD38-PE (130-123-571, Miltenyi Biotec), CD43-PE (130-112-887, Miltenyi Biotec), CD69-PE (130-115-575, Miltenyi Biotec), CD138 PE-Vio615 (130-108-989, Miltenyi Biotec), F4/80 FITC (130-117-509, Miltenyi Biotec), Ter119 PE (130-112-909, Miltenyi Biotec), SiglecH APC-Vio770 (130-112-299, Miltenyi Biotec), B220-APC (130-110-847, Miltenyi Biotec), B220 VioBlue (130-110-851, Miltenyi Biotec), IgM-VioBlue (130-116-318, Miltenyi Biotec), IgD-PE (130-111-496, Miltenyi Biotec), GL7-PE-Cy7 (144619, BioLegend), Ly6C-FITC (130111-915, Miltenyi Biotec), streptavidin FITC (554060, BD Biosciences), CD138 BV605 (563147, BD-Horizon), CD23 BV605 (101637, BioLegend), I-A/I-E BV711 (107643, BioLegend), CD19 BV786 (563333, BD Horizon), T and B cell activation antigen (GL7) PE (561530, BD Pharmingen), CD95 PE-Cy7 (557653, BD Pharmingen), IgM APC-eFluor 780 (47-5790-82, Invitrogen), CD45R/B220 APC/cyanine7 (103224, BioLegend), CD11b eFluor 450 (48-0112-82, eBioscience), CD267 (TACI) BV421 (742840, BD Biosciences), IgD BUV395 (564274, BD Horizon), streptavidin APC (4317-82, eBioscience), CD3 Biotin (100304, BioLegend), Biotin CD11c (568970, BD Biosciences), CD21 PercP Cy5.5 (562797, BD Biosciences), and Fixable Viability Dye eFluor 506 (65-0866-18, Invitrogen) following the recommendations of the manufacturers. .. Flow cytometry was conducted on a BD FACSAria Fusion (BD Biosciences) at the ImagoSeine platform of the Jacques Monod Institute (Paris, France).

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software

    Article Title: Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging.
    Article Snippet: Cells were blocked with rat anti-mouse CD16/CD32 antibody mix (BD Biosciences), then stained with Zombie UV Viability Dye (BioLegend; San Diego, CA). .. CD11b-APC, LY6C-FITC (Miltenyi Biotech; Gaithersburg, MD), and CD115-AlexaFluor532 (Novus Biological; Centennial, CO) antibodies were used for staining. .. The samples were processed with MoFlo Astrios EQ Cell Sorter (Beckman Coulter; Brea, CA) and analyzed using FlowJo v10.8 (BD Biosciences).

    Article Title: Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging
    Article Snippet: Cells were blocked with rat anti-mouse CD16/CD32 antibody mix (BD Biosciences), then stained with Zombie UV Viability Dye (BioLegend; San Diego, CA). .. CD11b-APC, LY6C-FITC (Miltenyi Biotech; Gaithersburg, MD), and CD115-AlexaFluor532 (Novus Biological; Centennial, CO) antibodies were used for staining. .. The samples were processed with MoFlo Astrios EQ Cell Sorter (Beckman Coulter; Brea, CA) and analyzed using FlowJo v10.8 (BD Biosciences).

    Activation Assay:

    Article Title: Altered X-chromosome inactivation predisposes to autoimmunity
    Article Snippet: Levels of inflammatory cytokines in sera were measured using a cytometric bead array mouse inflammation kit (552364, BD Biosciences) according to the manufacturer’s instructions. .. BM, spleen, blood, and peritoneal cavity cells were stained using the following antibodies: CD3 PerCP-Vio770 (130-119-656, Miltenyi Biotec), CD4-allophycocyanin (APC) (130-123-207, Miltenyi Biotec), CD5-APC-Vio770 (130-120-165, Miltenyi Biotec), CD8-fluorescein isothiocyanate (FITC) (130-118-468, Miltenyi Biotec), CD11b APC (553312, BD Pharmingen), CD11c phycoerythrin (PE)–Vio770 (130-110-840, Miltenyi Biotec), CD19-FITC (557398, BD Pharmingen), CD21-APC-Vio770 (130-111-733, Miltenyi Biotec), CD23-PE-Vio770 (130-118-764, Miltenyi Biotec), CD38-PE (130-123-571, Miltenyi Biotec), CD43-PE (130-112-887, Miltenyi Biotec), CD69-PE (130-115-575, Miltenyi Biotec), CD138 PE-Vio615 (130-108-989, Miltenyi Biotec), F4/80 FITC (130-117-509, Miltenyi Biotec), Ter119 PE (130-112-909, Miltenyi Biotec), SiglecH APC-Vio770 (130-112-299, Miltenyi Biotec), B220-APC (130-110-847, Miltenyi Biotec), B220 VioBlue (130-110-851, Miltenyi Biotec), IgM-VioBlue (130-116-318, Miltenyi Biotec), IgD-PE (130-111-496, Miltenyi Biotec), GL7-PE-Cy7 (144619, BioLegend), Ly6C-FITC (130111-915, Miltenyi Biotec), streptavidin FITC (554060, BD Biosciences), CD138 BV605 (563147, BD-Horizon), CD23 BV605 (101637, BioLegend), I-A/I-E BV711 (107643, BioLegend), CD19 BV786 (563333, BD Horizon), T and B cell activation antigen (GL7) PE (561530, BD Pharmingen), CD95 PE-Cy7 (557653, BD Pharmingen), IgM APC-eFluor 780 (47-5790-82, Invitrogen), CD45R/B220 APC/cyanine7 (103224, BioLegend), CD11b eFluor 450 (48-0112-82, eBioscience), CD267 (TACI) BV421 (742840, BD Biosciences), IgD BUV395 (564274, BD Horizon), streptavidin APC (4317-82, eBioscience), CD3 Biotin (100304, BioLegend), Biotin CD11c (568970, BD Biosciences), CD21 PercP Cy5.5 (562797, BD Biosciences), and Fixable Viability Dye eFluor 506 (65-0866-18, Invitrogen) following the recommendations of the manufacturers. .. Flow cytometry was conducted on a BD FACSAria Fusion (BD Biosciences) at the ImagoSeine platform of the Jacques Monod Institute (Paris, France).

    Article Title: Altered X-chromosome inactivation predisposes to autoimmunity.
    Article Snippet: .. 10, eadn6537 (2024) 3 May 2024 11 of 14 (PE)–Vio770 (130- 110- 840, Miltenyi Biotec), CD19- FITC (557398, BD Pharmingen), CD21- APC- Vio770 (130- 111- 733, Miltenyi Biotec), CD23- PE- Vio770 (130- 118- 764, Miltenyi Biotec), CD38- PE (130- 123- 571, Miltenyi Biotec), CD43- PE (130- 112- 887, Miltenyi Biotec), CD69- PE (130- 115- 575, Miltenyi Biotec), CD138 PEVio615 (130- 108- 989, Miltenyi Biotec), F4/80 FITC (130- 117- 509, Miltenyi Biotec), Ter119 PE (130- 112- 909, Miltenyi Biotec), SiglecH APC- Vio770 (130- 112- 299, Miltenyi Biotec), B220- APC (130- 110- 847, Miltenyi Biotec), B220 VioBlue (130- 110- 851, Miltenyi Biotec), IgM- VioBlue (130- 116- 318, Miltenyi Biotec), IgD- PE (130- 111- 496, Miltenyi Biotec), GL7- PE- Cy7 (144619, BioLegend), Ly6C- FITC (130111- 915, Miltenyi Biotec), streptavidin FITC (554060, BD Biosciences), CD138 BV605 (563147, BD- Horizon), CD23 BV605 (101637, BioLegend), I- A/I- E BV711 (107643, BioLegend), CD19 BV786 (563333, BD Horizon), T and B cell activation antigen (GL7) PE (561530, BD Pharmingen), CD95 PE- Cy7 (557653, BD Pharmingen), IgM APC- eFluor 780 (47- 5790- 82, Invitrogen), CD45R/ B220 APC/cyanine7 (103224, BioLegend), CD11b eFluor 450 (48- 0112- 82, eBioscience), CD267 (TACI) BV421 (742840, BD Biosciences), IgD BUV395 (564274, BD Horizon), streptavidin APC (4317- 82, eBioscience), CD3 Biotin (100304, BioLegend), Biotin CD11c (568970, BD Biosciences), CD21 PercP Cy5.5 (562797, BD Biosciences), and Fixable Viability Dye eFluor 506 (65- 0866- 18, Invitrogen) following the recommendations of the manufacturers. .. Flow cytometry was conducted on a BD FACSAria Fusion (BD Biosciences) at the ImagoSeine platform of the Jacques Monod Institute (Paris, France).

    Saline:

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software

    Lysis:

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software

    Blocking Assay:

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software

    Flow Cytometry:

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software

    Cell Isolation:

    Article Title: In vitro osteoclastogenesis assessment using murine myeloid-derived suppressor cells
    Article Snippet: 15 mL Centrifuge Tubes (#430053, Corning) Petri Dish 60 × 15 mm (#351007, Corning) 0.5 mL Centrifuge Tubes (#AB0350, Thermo Fisher Scientific) 1.5 mL Microcentrifuge Tubes (#69715, Thermo Fisher Scientific) 70 μm Cell Strainer (#431751, Corning) 96 well plate, U bottom (#353077, Corning) Round-Bottom Polystyrene Tubes with Caps, 5 mL (FASC tube, #38007, Falcon) Osteo Assay Surface (#3987, Corning) 24-well plate (#3526, Corning) 48-well plate (#3548, Corning) .. RPMI 1640 medium (#10-040-CV, Corning) MEM alpha media (#12571063, Gibco) Fetal Bovine Serum (#26140087, Gibco) Phosphate buffered saline (#10010-023, Gibco) Penicillin-Streptomycin (#15140148, Gibco) ACK lysis buffer (#A1049201, Gibco) FcR Blocking Reagent (#130-092-575, Miltenyi Biotec) Flow cytometry Staining Buffer (#00-4222-26, Invitrogen) CD11b-APC (#130-113-231, Miltenyi Biotec) Ly6C-FITC (#130-111-915, Miltenyi Biotec) Ly6G-PE (#130-102-392, Miltenyi Biotec) Myeloid-Derived Suppressor Cell Isolation Kit (#130-094-538, Miltenyi Biotec) CD3 MicroBead Kit (#130-094-973, Miltenyi Biotec) CellTrace Violet Cell Proliferation Kit (# C34571 , Invitrogen) Dynabeads Mouse T-Activator CD3/CD28 (#11452D, Gibco) CD3-APC (#130-109-838, Miltenyi Biotec) CD4-PE-Cyanine7 (#15370880, eBioscience) CD8-APC-Vio770 (#130-120-806, Miltenyi Biotec) Monocyte colony-stimulating factor (M-CSF, #416-ML-010, R&D Systems) RANKL (#462-TEC-010, R&D Systems) 0.2 M Sodium Acetate solution (#A13184, Thermo Fisher Scientific) 0.2 M Acetic Acid solution (#ACS003-78, BDH labs) 0.3 M Sodium Tartrate (#S-8640, Sigma) Naphthol AS-MX phosphate disodium salt (#N-5000, Sigma) FastRed Violet LB salt (#F-3381, Sigma) 15% Ehrlich’s hematoxylin (#26753-01, EMS) Paraformaldehyde (#J19943-K2, Thermo Fisher Scientific) Ethanol (#T038181000, Thermo Fisher Scientific) .. TC20 Automated Cell Counter (Bio-Rad) Humidified incubator (37 °C, 5% CO 2 ) Centrifuge (capable of spinning 15 mL conical tubes, 5 mL FACS tubes, and 96 well plates) BD LSRFortessa Cell Analyzer (BD Biosciences) BD FACSAria Cell Sorter (BD Biosciences) AutoMACS pro separator (Miltenyi Biotec) Water bath (Thermo Fisher Scientific) Image J analysis software Flowjo v10.9 software



    Similar Products

    94
    Miltenyi Biotec fitc ly6c
    Fitc Ly6c, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/Ly-6C+Antibody%2C+anti-mouse%2C+FITC/pmc11730596__41467_2024_55272_MOESM10_ESM-41-134-136
    Average 94 stars, based on 1 article reviews
    fitc ly6c - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Elabscience Biotechnology anti ly6c fitc
    Anti Ly6c Fitc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/FITC+Anti-Mouse+Ly6C+Antibody/pm40998135-101-13-16
    Average 93 stars, based on 1 article reviews
    anti ly6c fitc - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Proteintech ly6c
    Ly6c, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/FITC+Anti-mouse+Ly-6G/pm40579710-47-14-22
    Average 94 stars, based on 1 article reviews
    ly6c - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher ly6g/ly6c-fitc (gr-1) antibody
    Ly6g/Ly6c Fitc (Gr 1) Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/anti+gr+1/pm39813969-241-13-21
    Average 90 stars, based on 1 article reviews
    ly6g/ly6c-fitc (gr-1) antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec ly6c fitc
    Ly6c Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/Ly-6C+Antibody%2C+anti-mouse%2C+REAfinity/pmc11287231-27-44-46
    Average 95 stars, based on 1 article reviews
    ly6c fitc - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Thermo Fisher ly6c fitc
    Ly6c Fitc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/pm39447415-123-28-43
    Average 90 stars, based on 1 article reviews
    ly6c fitc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson fitc-conjugated anti-ly6c
    Fitc Conjugated Anti Ly6c, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/ly6g+antibody/pmc11377061-177-35-37
    Average 90 stars, based on 1 article reviews
    fitc-conjugated anti-ly6c - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson ly6c–fitc
    (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, <t>Ly6C,</t> CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.
    Ly6c–Fitc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/ly6g+antibody/bio_rxiv__2024__09__02__610822-192-25-28
    Average 90 stars, based on 1 article reviews
    ly6c–fitc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-ly6c–fitc
    (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, <t>Ly6C,</t> CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.
    Anti Ly6c–Fitc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ly6c+fitc/ly6g+antibody/bio_rxiv__2024__09__02__610822-196-25-28
    Average 90 stars, based on 1 article reviews
    anti-ly6c–fitc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, Ly6C, CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.

    Journal: bioRxiv

    Article Title: β-Glucan Reprograms Neutrophils to Induce Disease Tolerance Against Influenza A Virus

    doi: 10.1101/2024.09.02.610822

    Figure Lengend Snippet: (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, Ly6C, CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.

    Article Snippet: Antibodies for the innate panel: anti-CD11b–Pacific Blue (clone M1/70, eBioscience), anti-CD11c–PE-Cy7 (clone HL3, BD Bioscience), Siglec-F–PE-CF594 (clone E50– 2440, BD Bioscience), F4/80–APC (clone BM8, eBioscience), Ly6C–FITC (clone AL-21, BD Bioscience), Ly6G–PerCP-eFluor710 (clone 1A8, eBioscience).

    Techniques: Infection, Flow Cytometry, Control, Expressing, Fluorescence, Purification, Intravital Microscopy, Imaging

    (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, Ly6C, CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.

    Journal: bioRxiv

    Article Title: β-Glucan Reprograms Neutrophils to Induce Disease Tolerance Against Influenza A Virus

    doi: 10.1101/2024.09.02.610822

    Figure Lengend Snippet: (A-D) Mice were treated with β--glucan 6 days before influenza infection. On day 9 post-glucan treatment, blood (A-D) and Lung (E-H) neutrophils from infected and non-infected mice were extracted and their surface phenotype was assessed by spectral flow cytometry. (A) Uniform Manifold Approximation and Projection (UMAP) of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in two main Flowsom Clusters (cluster 1, grey and cluster 2, Cyan, 96% of neutrophils) (B) UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β--glucan +/- Influenza, Dark Blue). Neutrophil density repartition shows a shift of neutrophils in β-glucan treated group from Cluster 1 to Cluster 2. (C) Quantification of neutrophil repartition. (D) MFIs of selected markers are projected on the UMAP from (A). Histograms show MFIs from Cluster 1 (grey and cluster 2 (Cyan). Cluster 2 neutrophils exhibit lower expression of classical maturation markers CD101, Ly6G and CXCR2 and present with a less activated phenotype (CD62Lhigh, CD11blow, CD49dlow). (E) UMAP of CD11b+ Ly6G+ neutrophils from control and β--glucan treated mice with and without influenza infection. Neutrophils separate in 8 Flowsom Clusters. (F)UMAP from A is projected for the 4 experimental group (PBS +/- Influenza, black and β-glucan +/- Influenza, Dark Blue). Clusters 5, 6, and 8 expand dramatically during influenza infection. (G) Quantification of neutrophil present in influenza-driven clusters (Clusters 5, 6, 8). (H) MFIs of selected markers are projected on the UMAP from (E). Influenza-driven clusters exhibit an activated phenotype (CD14high, CD24high CD11b high, CD62Llow, CD49dlow). MFI Mean Fluorescence Intensity. UMAPs are based on 16 surface markers (CD45, Ly6G, CD101, CXCR2, CXCR4, CD62L, CD24, CD11b, CD49d, CD44, CCR2, Ly6C, CD80, MHCII, CD16, CD14). n=7. (I-O) Mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post- glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (J), basal respiration (K), maximal respiration (L), and ATP (M) production are shown. (N, O) Representative histogram plot and quantification (MFI) for mitochondrial mass using mitotracker green dye in the neutrophils of β-glucan-treated mice. (P) Representative 3-dimensional reconstructed lung intravital microscopy images from control or β-glucan treated Ly6G-TdTom mice. Mitotracker green dye was given i.v. prior to imaging. (Q) Mitochondria bright neutrophils were quantified. All scale bars = 50µm. (R-U) Ifnar1 -/- mice were treated with β-glucan. Neutrophils were purified from blood on day 4 post β-glucan treatment. Neutrophils’ cellular metabolism was determined by seahorse (R) and basal respiration (S). (T, U) Representative histogram plot (T) and quantification (MFI) for mitochondrial mass (U) using mitotracker green dye in the neutrophils from the lungs of β-glucan-treated Ifnar1 -/- mice. Data were analyzed using two-way ANOVA followed by Sidak’s multiple comparisons tests and unpaired t-test. * p<0.05, ** p <0.01, ***p<0.001.

    Article Snippet: Antibodies for the innate panel: anti- CD11b–Pacific Blue (clone M1/70, eBioscience), anti-CD11c–PE-Cy7 (clone HL3, BD Bioscience), anti-Siglec-F–PE-CF594 (clone E50–2440, BD Biosciences), anti-F4/80–APC (clone BM8, eBioscience), anti-Ly6C–FITC (clone AL-21, BD Bioscience), anti-Ly6G–PerCP– eFluor710 (clone 1A8, eBioscience).

    Techniques: Infection, Flow Cytometry, Control, Expressing, Fluorescence, Purification, Intravital Microscopy, Imaging